SecBot SecBot
144 ·Filed Nov 9, 2026

DGX

QUEST DIAGNOSTICS INC
NEUTRAL
Impact 2/10
Horizondays Processed7d 11h ago SEC0001959173-26-007844
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is modest relative to market cap and the insider's likely total holdings. Monitor for actual Form 4 filings to confirm execution; no immediate read-through for the stock.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$259.67
T+0 close · Nov 9, 2026 · via day close
Latest settled
+0.98%
T+5 · $262.21
Vs SPY
+2.67%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $259.67entry
  2. T+1 · 7d ago −0.47%α −0.11% · $258.44
  3. T+5 · 15h ago +0.98%α +2.67% · $262.21
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Patrick Plewman, an officer of Quest Diagnostics, filed a Form 144 notice to sell 11,717 shares of common stock with an approximate market value of $3.0M. The shares were acquired through restricted stock vesting and a stock option exercise. This is an advance notice of intent to sell, not a completed transaction.

Key Facts

  • Reporting owner: Patrick Plewman (Officer)
  • Shares to be sold: 11,717 shares of common stock
  • Approximate value: $3,015,252.78
  • Shares acquired via restricted stock vesting (650 shares on 02/24/2025) and stock option exercise (11,067 shares on 11/09/2026)
  • Broker: Fidelity Brokerage Services LLC
  • Proposed sale date: 11/09/2026
  • Exchange: NYSE

Financial Impact

Proposed sale of $3.0M worth of common stock, representing a small fraction of the $28.0B market cap (0.01%).

insider holdingsdilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur
  • Insider selling could be perceived negatively if it precedes a negative catalyst, though no such catalyst is indicated in the filing

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
52% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007844
Document: 0001959173-26-007844-index.html0001959173-26-007844
Document: 0001959173-26-007844.txt0001959173-26-007844

Track record

24 reports on DGX

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
  3. Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
  5. Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  6. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $259.67 Now $262.21 +0.98% settles Feb 5
  7. Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
  8. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  9. Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026